Oncology Experts

John A. Beutler

Associate Scientist, Molecular Targets Laboratory
Chemical Diversity Development Section, CCR
National Cancer Institute
United States of America


Dr. Beutler has identified several natural products which have potential for development as cancer drugs, among them, englerins, which are in preclinical development for kidney cancer and Ewing’s sarcoma, schweinfurthins, which are preclinical candidates in glioblastoma and malignant peripheral nerve sheath tumors, and salicylihalamides, of interest in sarcomas. As a staff scientist, Dr. Beutler oversees the Lab's high-throughput screening libraries, information technology, and drug development efforts. B.A., Chemistry, Vassar College, 1972 M.Sc., Philadelphia College of Pharmacy & Science, 1978 Ph.D., Philadelphia College of Pharmacy & Science, 1980 Postdoctoral Fellowships: Northeastern University, 1980-1 Assistant Professor, Auburn University School of Pharmacy, 1981-1983 University of Texas Medical School at Houston, 1983-4

Research Interest

1) natural products chemistry, 2) high-throughput screening, 3) molecular pharmacology,4) Cancer Biology, 5) Chemical Biology, 6) Molecular Pharmacology, 7) Virology

Global Experts from United States of America

Global Experts in Subject

Share This Profile